News center | United States​

Philips SimplyGo Mini portable oxygen concentrator conforms to FAA standards, now available for on board aircraft use

July 21, 2016

  • Link copied

Small, sleek and lightweight device gives homecare providers a new portable option for chronic respiratory patients who are on-the-go


Amsterdam, Netherlands – Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), announced today that their SimplyGo Mini portable oxygen concentrator (POC) conforms to all applicable Federal Aviation Administration (FAA) requirements for POC carriage and in-flight use on board aircraft*.


With the FAA’s acceptance notice, SimplyGo Mini becomes a new option for home medical equipment providers (HMEs) to offer today’s active respiratory patient, following the legacy of its proven predecessor, the SimplyGo. With its lightweight design and reliable therapy delivery system, SimplyGo Mini empowers patients who struggle with respiratory disorders to continue living full, engaged lives. SimplyGo Mini is the latest addition to Philips’ Right Fit portfolio of oxygen products and programs inspired by patients and built for HMEs to work more efficiently to meet the needs of their customers.


“Today’s HMEs are under tremendous pressure to operate smarter, more efficient businesses, and they need the right lineup of patient-centric products to support that effort,” said Eli Diacopoulos, Business Leader, Home Respiratory Care, Philips. “SimplyGo Mini addresses the importance and demand for mobility in today’s 24/7 world. Designed with the patient in mind, this device offers on-the-go respiratory patients an attractive, portable solution to travel with ease and convenience.”


The smallest and lightest POC in the Philips portfolio, SimplyGo Mini has undergone the same rigorous performance and reliability testing as traditional POC products. It offers an attractive and sleek design, as well as a strong, comfortable carrying case, appealing to today’s engaged and active patients. By conforming to the FAA’s standards for travel, Philips Respironics builds on its commitment to help address the needs and desires of patients living with chronic respiratory conditions who want to remain active and mobile.


In an effort to help HMEs streamline their businesses and make the most cost-effective use of resources while still providing high-quality patient care, the SimplyGo Mini is designed to deliver the following benefits:


  • Eliminates recurring oxygen delivery costs and cylinder hassles
  • Reduces maintenance costs
  • Eases inventory management
  • Minimizes patient calls


For more information on Philips’ sleep and respiratory care solutions call 800-345-6443 or visit, follow @PhilipsResp and the Philips Respironics Facebook page.



*Commercial airlines may have their own requirements for oxygen concentrators. Before flying in the U.S. or abroad, patients should contact their airlines for all connecting flights for permission to carry the SimplyGo Mini system on board.

  • Link copied

For further information, please contact:

Alicia Cafardi



About Philips Respironics:

Philips Respironics is a global leader in the sleep and respiratory care markets, offering solutions in sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery. With more than 10 years of cloud-based data sharing experience and analytics for more than 7 million patient lives, Philips Respironics has a long history of leading new innovation in both devices and informatics solutions to help patients sleep and breathe better.


About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.